198 related articles for article (PubMed ID: 29462945)
1. Luminal lncRNAs Regulation by ERα-Controlled Enhancers in a Ligand-Independent Manner in Breast Cancer Cells.
Miano V; Ferrero G; Rosti V; Manitta E; Elhasnaoui J; Basile G; De Bortoli M
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29462945
[TBL] [Abstract][Full Text] [Related]
2. Luminal long non-coding RNAs regulated by estrogen receptor alpha in a ligand-independent manner show functional roles in breast cancer.
Miano V; Ferrero G; Reineri S; Caizzi L; Annaratone L; Ricci L; Cutrupi S; Castellano I; Cordero F; De Bortoli M
Oncotarget; 2016 Jan; 7(3):3201-16. PubMed ID: 26621851
[TBL] [Abstract][Full Text] [Related]
3. LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network.
Zhang Y; Huang YX; Wang DL; Yang B; Yan HY; Lin LH; Li Y; Chen J; Xie LM; Huang YS; Liao JY; Hu KS; He JH; Saw PE; Xu X; Yin D
Theranostics; 2020; 10(23):10823-10837. PubMed ID: 32929382
[No Abstract] [Full Text] [Related]
4. Cooperativity of co-factor NR2F2 with Pioneer Factors GATA3, FOXA1 in promoting ERα function.
Jiang G; Wang X; Sheng D; Zhou L; Liu Y; Xu C; Liu S; Zhang J
Theranostics; 2019; 9(22):6501-6516. PubMed ID: 31588232
[TBL] [Abstract][Full Text] [Related]
5. NR2F2 Orphan Nuclear Receptor is Involved in Estrogen Receptor Alpha-Mediated Transcriptional Regulation in Luminal A Breast Cancer Cells.
Erdős E; Bálint BL
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32168782
[TBL] [Abstract][Full Text] [Related]
6. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
[TBL] [Abstract][Full Text] [Related]
7. Single-Molecule Sequencing Reveals Estrogen-Regulated Clinically Relevant lncRNAs in Breast Cancer.
Jonsson P; Coarfa C; Mesmar F; Raz T; Rajapakshe K; Thompson JF; Gunaratne PH; Williams C
Mol Endocrinol; 2015 Nov; 29(11):1634-45. PubMed ID: 26426411
[TBL] [Abstract][Full Text] [Related]
8. Estrogen induces dynamic ERα and RING1B recruitment to control gene and enhancer activities in luminal breast cancer.
Zhang Y; Chan HL; Garcia-Martinez L; Karl DL; Weich N; Slingerland JM; Verdun RE; Morey L
Sci Adv; 2020 Jun; 6(23):eaaz7249. PubMed ID: 32548262
[TBL] [Abstract][Full Text] [Related]
9. Dynamic assembly and activation of estrogen receptor α enhancers through coregulator switching.
Murakami S; Nagari A; Kraus WL
Genes Dev; 2017 Aug; 31(15):1535-1548. PubMed ID: 28887413
[TBL] [Abstract][Full Text] [Related]
10. Epigenomics-based identification of oestrogen-regulated long noncoding RNAs in ER+ breast cancer.
Zhang Z; Yu W; Tang D; Zhou Y; Bi M; Wang H; Zheng Y; Chen M; Li L; Xu X; Zhang W; Tao H; Jin VX; Liu Z; Chen L
RNA Biol; 2020 Nov; 17(11):1590-1602. PubMed ID: 32506995
[TBL] [Abstract][Full Text] [Related]
11. Identification and Analysis of Estrogen Receptor
Zhang X; Gao S; Li Z; Wang W; Liu G
Biomed Res Int; 2020; 2020():9031723. PubMed ID: 32420379
[TBL] [Abstract][Full Text] [Related]
12. Cellular reprogramming by the conjoint action of ERα, FOXA1, and GATA3 to a ligand-inducible growth state.
Kong SL; Li G; Loh SL; Sung WK; Liu ET
Mol Syst Biol; 2011 Aug; 7():526. PubMed ID: 21878914
[TBL] [Abstract][Full Text] [Related]
13. BAP18 facilitates CTCF-mediated chromatin accessible to regulate enhancer activity in breast cancer.
Sun G; Wei Y; Zhou B; Wang M; Luan R; Bai Y; Li H; Wang S; Zheng D; Wang C; Wang S; Zeng K; Liu S; Lin L; He M; Zhang Q; Zhao Y
Cell Death Differ; 2023 May; 30(5):1260-1278. PubMed ID: 36828916
[TBL] [Abstract][Full Text] [Related]
14. The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progression.
Niknafs YS; Han S; Ma T; Speers C; Zhang C; Wilder-Romans K; Iyer MK; Pitchiaya S; Malik R; Hosono Y; Prensner JR; Poliakov A; Singhal U; Xiao L; Kregel S; Siebenaler RF; Zhao SG; Uhl M; Gawronski A; Hayes DF; Pierce LJ; Cao X; Collins C; Backofen R; Sahinalp CS; Rae JM; Chinnaiyan AM; Feng FY
Nat Commun; 2016 Sep; 7():12791. PubMed ID: 27666543
[TBL] [Abstract][Full Text] [Related]
15. Amplification of WHSC1L1 regulates expression and estrogen-independent activation of ERα in SUM-44 breast cancer cells and is associated with ERα over-expression in breast cancer.
Irish JC; Mills JN; Turner-Ivey B; Wilson RC; Guest ST; Rutkovsky A; Dombkowski A; Kappler CS; Hardiman G; Ethier SP
Mol Oncol; 2016 Jun; 10(6):850-65. PubMed ID: 27005559
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of the long noncoding RNAs DSCAM-AS1 and MANCR is a potential diagnostic marker for breast carcinoma.
Tahmouresi F; Razmara E; Pakravan K; Mossahebi-Mohammadi M; Rouhollah F; Montazeri M; Sarrafzadeh A; Fahimi H; Babashah S
Biotechnol Appl Biochem; 2021 Dec; 68(6):1250-1256. PubMed ID: 33012018
[TBL] [Abstract][Full Text] [Related]
17. LncRNA H19 confers chemoresistance in ERα-positive breast cancer through epigenetic silencing of the pro-apoptotic gene BIK.
Si X; Zang R; Zhang E; Liu Y; Shi X; Zhang E; Shao L; Li A; Yang N; Han X; Pan B; Zhang Z; Sun L; Sun Y
Oncotarget; 2016 Dec; 7(49):81452-81462. PubMed ID: 27845892
[TBL] [Abstract][Full Text] [Related]
18. Alternatively Constructed Estrogen Receptor Alpha-Driven Super-Enhancers Result in Similar Gene Expression in Breast and Endometrial Cell Lines.
Bojcsuk D; Nagy G; Bálint BL
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32120995
[TBL] [Abstract][Full Text] [Related]
19. Nonlinear relationship between chromatin accessibility and estradiol-regulated gene expression.
Chen D; Parker TM; Bhat-Nakshatri P; Chu X; Liu Y; Wang Y; Nakshatri H
Oncogene; 2021 Feb; 40(7):1332-1346. PubMed ID: 33420376
[TBL] [Abstract][Full Text] [Related]
20. FGF2 induces breast cancer growth through ligand-independent activation and recruitment of ERα and PRBΔ4 isoform to MYC regulatory sequences.
Giulianelli S; Riggio M; Guillardoy T; Pérez Piñero C; Gorostiaga MA; Sequeira G; Pataccini G; Abascal MF; Toledo MF; Jacobsen BM; Guerreiro AC; Barros A; Novaro V; Monteiro FL; Amado F; Gass H; Abba M; Helguero LA; Lanari C
Int J Cancer; 2019 Oct; 145(7):1874-1888. PubMed ID: 30843188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
